Page 8 - Farmacovigilancia en Oncología

Referencias
1. Pharmacovigilance in oncology Paolo Baldo1 · Giulia Fornasier1 · Laura Ciolfi2 · Ivana Sartor3 · Sara Frances-
con1 Received: 30 January 2018 / Accepted: 26 July 2018 / Published online: 1 August 2018. International
Journal of Clinical Pharmacy (2018) 40:832–841
2. Br J Clin Pharmacol / 78:2 / 218–243. Substandard drugs:a potential crisis for public healthAtholl Johnston1
& David W. Holt21Clinical Pharmacology, Barts and The London School of Medicine and Dentistry, Queen
Mary University of London, London, UK and 2St George’s – University of London, London, UK. Published
Online 29 November 2013.
3. http://www.mhra.gov.uk/spc-pil/
4. BC Cancer Agency. Cancer Drug Manual Drug Index [Internet]. Vancouver, British Columbia [updated
continuously]. Available from: http://www.bccancer.bc.ca/health-professionals/professional-resources/can-
cer-drug-manual/drug-index.
5. Value in Oncology: Balance Between Quality and Cost Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, and
Mark W. Legnini, DrPH. https://ascopubs.org/doi/full/10.1200/EDBK_100003 American Society of Clinical
Oncology Educational Book 36 (October 29, 2018) 9-13.

Fresenius Kabi Chile Ltda.
Pintor Cicarelli 235,
San Joaquín, Santiago - Chile
Tel.: 2462 70 00 - Fax: 2551 65 53
www.fresenius-kabi.cl

MK-MPON-053